Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans.
about
An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathwayHuman apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changesRare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart diseaseCholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community.Lecithin: cholesterol acyltransferase--from biochemistry to role in cardiovascular disease.Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator of macrophage reverse cholesterol transport in vivo.Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular diseaseCholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis.Plasma lecithin:cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular riskModification of CETP function by changing its substrate preference: a new paradigm for CETP drug designAnalysis of cholesteryl esters and diacylglycerols using lithiated adducts and electrospray ionization-tandem mass spectrometryMolecular regulation of HDL metabolism and function: implications for novel therapies.Electrospray ionization tandem mass spectrometry of sodiated adducts of cholesteryl esters.Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice.Future therapeutic directions in reverse cholesterol transport.High Density Lipoprotein (HDL) Modulation Targets.Torcetrapib/atorvastatin combination therapy.High-Density Lipoprotein - A Hero, a Mirage, or a Witness?Measurement of reverse cholesterol transport pathways in humans: in vivo rates of free cholesterol efflux, esterification, and excretionA physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humansAssays of plasma dehydrocholesteryl esters and oxysterols from Smith-Lemli-Opitz syndrome patientsThematic review series: patient-oriented research. What have we learned about HDL metabolism from kinetics studies in humans?High-density lipoproteins: a therapeutic target for atherosclerotic cardiovascular disease.Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.CETP inhibition in cardiovascular risk management: a critical appraisal.Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.Nanocrystal Core Lipoprotein Biomimetics for Imaging of Lipoproteins and Associated Diseases.In silico modeling of the dynamics of low density lipoprotein composition via a single plasma sample.Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart StudyAssociation of CETP Taq1B and -629C > A polymorphisms with coronary artery disease and lipid levels in the multi-ethnic Singaporean populationSelective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis.Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport.A fluorescence method to detect and quantitate sterol esterification by lecithin:cholesterol acyltransferaseCholesteryl ester transfer protein protects against insulin resistance in obese female mice.Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.2H2O-based high-density lipoprotein turnover method for the assessment of dynamic high-density lipoprotein function in mice.
P2860
Q28540807-2C170B7F-6792-4751-94BB-6C96F92E1A4CQ28570515-D7EEDF2E-976C-4B98-A26C-E0FE6281C623Q29147547-3330B40B-210F-482E-9805-9790E738E716Q33590777-304441BF-5097-4C5B-B7C9-DA9D2839C454Q33639433-30EB5309-A227-4661-9F05-B04340870A4CQ34021570-DBDE2F2B-F5BB-4E24-AFF1-518ED6B56AE1Q34048490-0D25C3D2-66FE-4C3A-B91A-EC1418C465F3Q34155049-8E1DF639-77BA-47C3-95F6-4DCD62131998Q34218552-4138741C-B7C7-4BF1-A4ED-8DD71013C5FCQ34948139-C5E72BF3-295C-4A95-850F-B26E191C4A28Q35107313-4629485B-F99F-41C3-BFE7-ECC8ABE011CCQ35120922-3EA6CDC2-2536-4A4C-A140-C51D9129E0FEQ35154107-484F8974-2E97-4676-9641-1A27EA93D68EQ35191066-B6B14035-3C50-4620-B840-ABF776321B4EQ35549485-513801CF-D248-4CDE-A8D3-A375F497A3EDQ35590298-A38569AB-C988-4C37-980E-EE09E79A2454Q35776623-10287BD6-A2CB-427A-945A-EA94CFFC6B1AQ35860010-B5C609AF-262F-4429-AFEB-A4E956DD4168Q36053317-BF60CB6E-D552-4CCD-A25B-3ED970443A33Q36265996-513984ED-CC49-4E59-8A00-71990DA422AFQ36344712-B240A229-5761-459B-9696-B17185816951Q36366317-88A14FA7-6785-4770-812C-DEB5697012ECQ36387268-61980FC1-EFFF-441F-9E97-B2700FC85083Q36462089-F17AB154-CCB3-42D4-8C4F-0E0D64F38631Q36473656-75DD6B1A-A381-4F9A-B539-AD8D29849DA9Q36539475-4A7707C5-0FD6-43B5-8278-433FCFF8969BQ36540608-7E7C0192-A7B8-482D-8C5A-20C3DFF91B18Q36705260-D2FE7219-FDD9-4A12-B68F-CCF3DE275338Q36783281-DD6E4B09-B31F-45F8-B76B-E0B68F705E25Q36841990-E70C2FD5-2A69-4AF9-AB89-7303949CE6FFQ36843279-4E3E1897-2BB5-4FA8-AE2A-CC0F3EAB9F3FQ36953767-2F0E0A8B-B4A1-4C09-923A-F677D51473ECQ36976136-A5073299-1BD3-481C-9F26-3CA4A7BF21E2Q37151837-15B07220-6A1C-4620-9B9A-2C2173BB8F36Q37179542-AD97C27F-A7FD-4A8E-B750-F9EC62D8B3B9Q37236276-7E99F64A-BD34-478B-B174-99E5F78A7FBDQ37293943-27FF7D3A-606B-45F6-B36E-BDE347174FF4Q37372858-DAF167CB-009F-4FB3-A639-1692665B274AQ37456662-68407548-8542-4F51-8E0B-CDB56920A71FQ37645650-D448439A-6BF8-4BD0-ACBF-682E724FBCFE
P2860
Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans.
@en
Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans.
@nl
type
label
Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans.
@en
Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans.
@nl
prefLabel
Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans.
@en
Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans.
@nl
P2093
P2860
P1476
Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans.
@en
P2093
Charles C Schwartz
Julie M VandenBroek
Patricia S Cooper
P2860
P304
P356
10.1194/JLR.M300511-JLR200
P577
2004-05-16T00:00:00Z